Cognitive activity for the treatment of older adults with mild Alzheimer's Disease (AD) - PACE AD: study protocol for a randomised controlled trial

Table 1 Outline of the primary and secondary outcome measures used in the PACE-AD trial

The X indicates who completed the respective assessments (participant with mild AD or companion). All measures were given at baseline, 13 and 26 weeks.
ADAS-COG = Alzheimer Disease Assessment Scale-Cognitive; RBMT-3 = Rivermead Behavioural Memory Test-Third Edition; ToL = Tower of London; COWAT = Controlled Oral Word Association Test; MMSE = Mini Mental State Examination; PHQ-9 = Patient Health Questionnaire - Nine Item; Short-Form IQ CODE = Modified Short Form of the Informant Questionnaire on Cognitive Decline in the Elderly; IADL = The Lawton Instrumental Activities of Daily Living; NPI-Q = The Neuropsychiatric Inventory Questionnaire; AUDIT = World Health Organisation's Alcohol Use Disorders Identification Test; SF-12 = Short-Form 12-Item Health Survey.

ISSN: 1745-6215